A Partner in Health
A new chapter, a new approach. Collaborating with physicians and other healthcare professionals, focusing on R&D and maintaining clinical leadership add up to innovative medical solutions that make a difference.
Work with Us
Join Covidien, where we appreciate your talent, your experience and your passion for your work. Our culture thrives because we invest in our colleagues' growth and reward their efforts.
COV (NYSE)
| Price: | $52.96 |
| Change: | (0.10) |
| Volume: | 2,684,453 |
Minimum 20 minute delay
-
9/4/2008 5:30:00 AM
BOULDER, Colo., Sep 04, 2008 (BUSINESS WIRE) -- Covidien (NYSE: COV, BSX: COV), a world leader in advanced energy-based surgical systems, today announced the global release of the Evident(TM) microwave ablation system. Physicians now have a powerful new tool with industry-lea... -
9/2/2008 7:00:00 AM
MANSFIELD, Mass.--(BUSINESS WIRE)--Sept. 2, 2008--Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has reached an agreement with Purdue Pharma L.P. to end a patent infringement lawsuit between them. I...
-
8/26/2008 7:01:00 AM
Covidien Announces Agenda for Investor Meeting on September 10, 2008
HAMILTON, Bermuda--(BUSINESS WIRE)--Aug. 26, 2008--Covidien Ltd. (NYSE: COV; BSX: COV), a leading global provider of healthcare products, today announced the agenda for its investor meeting on Wednesday, September 10, 2008. The event will be held at the Pierre Hotel, Fifth Avenue at 61st ...
-
8/19/2008 8:03:00 AM
Covidien Announces Establishment of Covidien Ventures
HAMILTON, Bermuda--(BUSINESS WIRE)--Aug. 19, 2008--Covidien Ltd. (NYSE: COV; BSX: COV), a leading global provider of healthcare products, today announced that it has established Covidien Ventures, a corporate venture capital function. Covidien Ventures will invest in areas of strategic im...